Immune Reconstitution Inflammatory Syndrome
2
Pipeline Programs
2
Companies
1
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
U
METHYLPREDNISOLONE SODIUM SUCCINATEApproved
methylprednisolone
Unknown Companyinjection2016
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiogenMethylprednisolone
Clinical Trials (1)
Total enrollment: 3 patients across 1 trials
Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
Start: Sep 2010Est. completion: Feb 20123 patients
Phase 4Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space